Safety and efficacy of conditioning regimen with fludarabine and targeted dose intravenous busulfan for elderly patinets

Trial Profile

Safety and efficacy of conditioning regimen with fludarabine and targeted dose intravenous busulfan for elderly patinets

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 May 2016

At a glance

  • Drugs Busulfan (Primary) ; Fludarabine (Primary)
  • Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 29 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top